Literature DB >> 24053396

Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.

Sushant Sahastrabuddhe1, Rodney Carbis, Thomas F Wierzba, R Leon Ochiai.   

Abstract

Enteric fever caused by Salmonella enterica serovar Typhi and Salmonella enterica serovar Paratyphi is still a major disease burden mainly in developing countries. Previously, S. Typhi was believed to be the major cause of enteric fever. The real situation is now becoming clear with reports emerging from many Asian countries of S. Paratyphi, mostly S. Paratyphi A, causing a substantial number of cases of enteric fever. Although there have been advances in the use of the currently available typhoid vaccines and in the development of newer typhoid vaccines, paratyphoid vaccine development is lagging behind. Since the disease caused by S. Typhi and S. Paratyphi are clinically indistinguishable and are commonly termed 'enteric' fever, it will be necessary to have a vaccine available against both S. Typhi and S. Paratyphi A as a bivalent 'enteric fever vaccine'.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24053396     DOI: 10.1586/14760584.2013.825450

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  25 in total

1.  Six Cases of Paratyphoid Fever Due to Salmonella Paratyphi A in Travelers Returning from Myanmar Between July 2014 and August 2015.

Authors:  Yuichi Katanami; Satoshi Kutsuna; Masatomo Morita; Hidemasa Izumiya; Makoto Ohnishi; Kei Yamamoto; Nozomi Takeshita; Kayoko Hayakawa; Shuzo Kanagawa; Yasuyuki Kato; Norio Ohmagari
Journal:  Am J Trop Med Hyg       Date:  2016-06-27       Impact factor: 2.345

Review 2.  Live attenuated vaccines for invasive Salmonella infections.

Authors:  Sharon M Tennant; Myron M Levine
Journal:  Vaccine       Date:  2015-04-19       Impact factor: 3.641

3.  Generation and Characterization of Typhoid Toxin-Neutralizing Human Monoclonal Antibodies.

Authors:  Xuyao Jiao; Sarah Smith; Gabrielle Stack; Qi Liang; Allan Bradley; Paul Kellam; Jorge E Galán
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

4.  Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.

Authors:  Aamir Ali; So J An; Changfa Cui; Abdul Haque; Rodney Carbis
Journal:  Hum Vaccin Immunother       Date:  2014-03-06       Impact factor: 3.452

5.  Syntheses of Salmonella Paratyphi A Associated Oligosaccharide Antigens and Development towards Anti-Paratyphoid Fever Vaccines.

Authors:  Debashis Dhara; Scott M Baliban; Chang-Xin Huo; Zahra Rashidijahanabad; Khandra T Sears; Setare Tahmasebi Nick; Anup Kumar Misra; Sharon M Tennant; Xuefei Huang
Journal:  Chemistry       Date:  2020-10-22       Impact factor: 5.236

6.  Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States, 2008-2012.

Authors:  Kashmira A Date; Anna E Newton; Felicita Medalla; Anna Blackstock; LaTonia Richardson; Andre McCullough; Eric D Mintz; Barbara E Mahon
Journal:  Clin Infect Dis       Date:  2016-04-18       Impact factor: 9.079

7.  Effectiveness of typhoid vaccination in US travelers.

Authors:  Barbara E Mahon; Anna E Newton; Eric D Mintz
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

8.  Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers.

Authors:  David McCullagh; Hazel C Dobinson; Thomas Darton; Danielle Campbell; Claire Jones; Matthew Snape; Zoe Stevens; Emma Plested; Merryn Voysey; Simon Kerridge; Laura B Martin; Brian Angus; Andrew J Pollard
Journal:  BMJ Open       Date:  2015-06-16       Impact factor: 2.692

9.  Salmonella enterica Paratyphi A Infections in Travelers Returning from Cambodia, United States.

Authors:  Michael C Judd; Julian E Grass; Eric D Mintz; Amelia Bicknese; Barbara E Mahon
Journal:  Emerg Infect Dis       Date:  2015-06       Impact factor: 6.883

Review 10.  Vaccines against invasive Salmonella disease: current status and future directions.

Authors:  Calman A MacLennan; Laura B Martin; Francesca Micoli
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.